Identification of PML/RARa fusion gene transcripts that showed no t(15;17) with conventional karyotyping and fluorescent in situ hybridization

Genetics and Molecular Research

Volumn 8, Issue 1, 2009, Pages 1-7

  Choughule, A ^a   Polampalli, S ^a   Amre, P ^a   Shinde, S ^a   Banavali, S ^a   Prabhash, K ^a   Nair, R ^a   Subramanian, P G ^a   Gujral, S ^a   Parikh, P M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Acute promyelocytic leukemia; Cryptic insertions; Fluorescence in situ hybridization; Promyelocytic leukemia retinoic acid receptor alpha; Reverse transcription polymerase chain reaction; Sequencing analysis

Indexed keywords

ARSENIC; CYTARABINE; DAUNORUBICIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; MESSENGER RNA; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME DELETION; CLINICAL FEATURE; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA REMISSION; MALE; MULTIPLE CYCLE TREATMENT; PROMYELOCYTIC LEUKEMIA; PROTHROMBIN TIME; RECIPROCAL CHROMOSOME TRANSLOCATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENE TRANSLOCATION; GENETICS; MIDDLE AGED;

ADULT; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 66349085066     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol8-1gmr488     Document Type: Article

References (20)

1. Ades L, Chevret S, Raffoux E, de Botton S, et al. (2006). Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. J. Clin. Oncol. 24: 5703-5710.
2. Allford S, Grimwade D, Langabeer S, Duprez E, et al. (1999). Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party. Br. J. Haematol. 105: 198-207.
3. Amare PS, Baisane C, Saikia T, Nair R, et al. (2001). Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias. Cancer Genet. Cytogenet. 131: 125-134.
4. Biondi A, Rambaldi A, Alcalay M, Pandolfi PP, et al. (1991). RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood 77: 1418-1422.
5. de Botton S, Coiteux V, Chevret S, Rayon C, et al. (2004). Outcome of childhood acute promyelocytic leukemia with all- trans-retinoic acid and chemotherapy. J. Clin. Oncol. 22: 1404-1412.
6. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, et al. (2000). Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". Blood 96: 1297-1308.
7. Head D, Kopecky KJ, Weick J, Files JC, et al. (1995). Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood 86: 1717-1728.
8. Hiorns LR, Min T, Swansbury GJ, Zelent A, et al. (1994). Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood 83: 2946-2951.
9. ISCN (1995). An International System for Human Cytogenetic Nomenclature (Mitelman F, ed.). S. Karger, Basel.
10. Lo Coco F, Diverio D, Falini B, Biondi A, et al. (1999). Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 94: 12-22.
11. Mathews V, George B, Lakshmi KM, Viswabandya A, et al. (2006). Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 107: 2627-2632.
12. Oh SH, Park TS, Kim HH, Chang CL, et al. (2003). Tetraploid acute promyelocytic leukemia with double t(15;17) and PML/RARA rearrangements detected by fluorescence in situ hybridization analysis. Cancer Genet. Cytogenet. 145: 49-53.
13. Owatari S, Uozumi K, Haraguchi K, Ohno N, et al. (2007). A new cytogenetic abnormality, t(2;7)(q33;q36), in acute promyelocytic leukemia. Cancer Genet. Cytogenet. 173: 71-74.
14. Pinkel D, Straume T and Gray JW (1986). Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. U. S. A. 83: 2934-2938.
15. Rowley JD, Golomb HM and Dougherty C (1977). 15/17 Translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1: 549-550.
16. Seabright M (1971). A rapid banding technique for human chromosomes. Lancet 2: 971-972.
17. Stone RM and Mayer RJ (1990). The unique aspects of acute promyelocytic leukemia. J. Clin. Oncol. 8: 1913-1921.
18. Tijo JH and Whang J (1965). Direct Chromosome Preparation of Bone Marrow Cells. In: Human Chromosome Methodology (Yunis JJ, ed.). Academic Press, New York, 51-56.
19. Tobal K and Liu Yin JA (1998). RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL. Leukemia 12: 1349-1354.
20. Zaccaria A, Valenti A, Toschi M, Salvucci M, et al. (2002). Cryptic translocation of PML/RARA on 17q. A rare event in acute promyelocytic leukemia. Cancer Genet. Cytogenet. 138: 169-173.